A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms
Status: Recruiting
Location: See all (52) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles.
• Willing and able to provide informed consent and to participate in all evaluations.
Locations
United States
Arkansas
University of Arkansas Medical Center
RECRUITING
Little Rock
Arizona
HonorHeath Scottsdale Osborn Medical Center
RECRUITING
Phoenix
California
Eden Medical Center
RECRUITING
Castro Valley
UCSD Moores Cancer Center
RECRUITING
La Jolla
MemorialCare Health System
RECRUITING
Laguna Hills
Desert Regional Medical Center
RECRUITING
Palm Springs
California Pacific Medical Center, Sutter health
RECRUITING
San Francisco
Colorado
Centura
NOT_YET_RECRUITING
Denver
Colorado Brain & Spine Institute: Swedish Campus
RECRUITING
Englewood
Florida
BayCare Health
RECRUITING
Clearwater
Miami Cancer Institute, Baptist Health South Florida
RECRUITING
Miami
Advent Health Orlando
RECRUITING
Orlando
Orlando Health
RECRUITING
Orlando
Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital
RECRUITING
Tampa
Cleveland Clinic Florida- Weston
RECRUITING
Weston
Georgia
Piedmont Healthcare
RECRUITING
Atlanta
Winship Cancer Institute of Emory University
RECRUITING
Atlanta
Idaho
St. Alphonsus Regional Medical Center
RECRUITING
Boise
Indiana
Indiana University, IU Health Methodist Hospital
RECRUITING
Indianapolis
Kansas
KUMC Dept of Neurosurgery
RECRUITING
Kansas City
Kentucky
Norton Cancer Institute
RECRUITING
Louisville
Univeristy of Louisville Health
RECRUITING
Louisville
Louisiana
Willis-Knighton Medical Center
WITHDRAWN
Shreveport
Massachusetts
Beth Israel Deaconess Medical Center
RECRUITING
Boston
Beth Israel Deaconess Medical Center
RECRUITING
Boston
Michigan
Henry Ford Health System
RECRUITING
Detroit
Minnesota
Abbott Northwestern Hospital
RECRUITING
Minneapolis
University of Minnesota
RECRUITING
Minneapolis
North Carolina
University of North Carolina Health
RECRUITING
Chapel Hill
Vidant Heath - ECU Medical Center
RECRUITING
Greenville
Atlantic Brain & Spine
RECRUITING
Wilmington
Nebraska
University of Nebraska
RECRUITING
Omaha
New Jersey
Clinical Research dep. Davison Place. Englewood Health
NOT_YET_RECRUITING
Englewood
New York
Albany Medical Center
RECRUITING
Albany
Mount Sinai Hospital
ACTIVE_NOT_RECRUITING
New York
SUNY Upstate Medical Center
RECRUITING
Syracuse
Montefiore Einstein
RECRUITING
The Bronx
Westchester Medical Center
RECRUITING
Valhalla
Ohio
Mayfield Brain and Spine
RECRUITING
Cincinnati
Kettering Health
RECRUITING
Kettering
Pennsylvania
St Luke's University Health, Sacred Heart Campus
RECRUITING
Allentown
Penn State Health
RECRUITING
Hershey
Allegheny Health Network
RECRUITING
Pittsburgh
Rhode Island
Brown University Health
RECRUITING
Providence
Tennessee
CHI Memorial Hospital, CommonSpirit
RECRUITING
Chattanooga
Texas
UT Southwestern Simmons Cancer Center
RECRUITING
Dallas
Baylor St. Luke's Medical Center | Baylor College of Medicine
RECRUITING
Houston
Houston Methodist Hospital
RECRUITING
Houston
University of Texas Health Science Center of San Antonio
RECRUITING
San Antonio
Texas Oncology-The Woodlands
RECRUITING
The Woodlands
Virginia
INOVA Health
RECRUITING
Fairfax
Washington
Virginia Mason
RECRUITING
Seattle
Contact Information
Primary
Michael A. Garcia, MD, MS
mgarcia@gtmedtech.com
(833) 662-0044
Backup
Sita Patel, PhD, PharmD
spatel@gtmedtech.com
(833)662-0044
Time Frame
Start Date: 2020-09-11
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 600
Treatments
GammaTile
Patients who have received permanent implants of GammaTile radiation therapy immediately following brain tumor resection.
Related Therapeutic Areas
Sponsors
Leads: GT Medical Technologies, Inc.